Evaluation of H9N2 influenza vaccines in Balb/c mice

International Congress Series

Volumn 1219, Issue C, 2001, Pages 789-794

  Major, D L ^a   Newman, R W ^a   Dunleavy, U ^a   Heath, A B ^a   Ploss, K ^a   Wood, J M ^a  

^a NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

Author keywords

Animal model; Challenge; Neuraminidase; Protection

Indexed keywords

EID: 0012070376     PISSN: 05315131     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0531-5131(01)00357-0     Document Type: Article

References (7)

1. Lin, Y.P., Shaw, M., Gregory, V., Cameron, K., Lim, W., Klimov, A., Subbarao, K., Guan, Y., Krauss, S., Shortridge, K., Webster, R., Cox, N., Hay, A., Avian-to-human transmission of H9N2 subtype influenza A viruses: relationship between H9N2 and H5N1 human isolates. Proc. Natl. Acad. Sci. U. S. A. 96 (2000), 9654–9658.
2. Wood, J.M., Schild, G.C., Newman, R.W., Seagroatt, V., An improved single radial immunodiffusion technique for the assay of influenza haemagglutinin antigen: application for potency determinations of inactivated whole virus and subunit vaccines. J. Biol. Stand. 5 (1977), 237–247.
3. A.P. Kendal, M.S. Pereira, J.J. Skehel, 1982. Concepts and Procedures for Laboratory-Based Influenza Surveillance. U.S. Department of Health and Human Services, (Centers Dis. Control, Atlanta).
4. Brokstad, A.B., Cox, R.J., Major, D., Wood, J.M., Haaheim, L.R., Cross-reaction but no avidity change of the serum antibody response after influenza vaccination. Vaccine 13 (1995), 1522–1528.
5. Nichol, K.L., Efficacy/clinical effectiveness of inactivated influenza virus vaccines in adults. Nicholson, K.G., Webster, R.G., Hay, A.J., (eds.) Textbook of Influenza, 1998, Blackwell, Oxford, 358–372.
6. Amerding, D., Rossiter, H., Ghazzouli, I., Liehl, E., Evaluation of live and inactivated influenza A virus vaccines in a mouse model. J. Infect. Dis. 145 (1982), 320–330.
7. Johansson, B.E., Bucher, D.J., Kilbourne, E.D., Purified influenza virus haemagglutinin and neuraminidase are equivalent in stimulation of antibody response but induce contrasting types of immunity to infection. J. Virol. 63 (1988), 1239–1246.